Intrinsic Value

LBTD latest financial reports are more than 5 years old.
LBTD doesn't have a meaningful market cap.
Not Available for LBTD

There is not enough data to reliably calculate the intrinsic value for Lotus Bio-Technology Development Corp.

Do our valuations actually work? See backtest results .

Alternatives to LBTD

Fundamental Analysis

What Lotus Bio-Technology Development Does

Lotus Bio-Technology Development Corp. engages in improving healthcare and advancing diagnostics through technology development and market acquisition. The company is headquartered in Costa Mesa, California. The company went IPO on 2013-03-14. The firm delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections.

Headquarters
United States of America US
IPO date
Mar 14, 2013
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Lotus Bio-Technology Development Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape